Copeland Clinical AI
Unique multi-award winning AI systems to saves $bn's and thousands of lives
Our systems uniquely, objectively and accurately risk adjust for each patient and can tell which hospitals, specialties, consultants etc. are doing well (given their specific case-mix), where the hospital has issues for mortality and complications, what the causes are, their economic impact, and how to resolve them.
This means we tackle the variation and harm that is the key industry issue – delivering the silver bullet which is reduction in total cost of care (around $3-10m of direct costs per annum), while also demonstrably improving patient outcomes and up to 10% of clinical negligence costs.
Our approach is so effective, we are able to identify and help hospitals resolve the 83% of harms that even a US hospital group reputed for aviation standards of patient safety was not aware of (and 90% of harms in typical harms).
C2-Ai solutions can then support hospitals with forward-looking applications to triage and manage patients more effectively - optimising outcomes and cost-effectiveness. At scale in the NHS this would save 70,000 lives annually and £1bn.
C2-AI systems are not disruptive and no integration is required.
Date of establishment：
Fundraising round：Website address
C2-AI are global leaders in helping hospitals reduce issues such as Acute Kidney Injury (among other…more...
Reducing Hospital-Acquired Acute Kidney Injury (HA-AKI) and Hospital Acquired Pneumonia
Contact person：Richard Jones
Mobile：+44 7811 166033
President and Chief Commercial Officer